Paurvi Shinde
  • Post-Doc, Fred Hutchinson Cancer Research Center
Research focus
  • Immunology
  • Viral infections, HSV-2, HIV-1, ZIka, WNV, primary and memory T cells, Tregs and dendritic cell responses, TLR signaling, adjuvants and costimulatory receptors, flow cytometry, cell sorting, in vitro T cell, DC, and Treg assays.


Doctorate, University of Connecticut Health, 2017

Lab information

Jennifer Lund Lab


1. Shinde, P., Bharat, V., Rodriguez-Oquendo, A., Zhou, B. and Vella, A.T. Understanding how combinatorial targeting of TLRs and TNFR family costimulatory members promote enhanced T cell responses. (Accepted in Sept 2018, Expert Opinion on Biological Therapy).

2. Shinde, P., Liu, W., Ménoret, A., Luster, A. D., Vella, A. T. (2017) Optimal CD4 T cell priming after LPS-based adjuvanticity with CD134 costimulation relies on CXCL9 production. J Leukoc Biol.; doi:10.1189/jlb.1A0616-261RR.

3. Mukherjee S, Trice J, Shinde P, Willis RE, Pressley TA, Perez-Zoghbi JF. (2013) Ca2+ oscillations, Ca2+ sensitization, and contraction activated by protein kinase C in small airway smooth muscle. J Gen Physiol.; doi: 10.1085/jgp.201210876.
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.